Detalhe da pesquisa
1.
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 71(7): e31051, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706187
2.
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
Pediatr Blood Cancer
; 68(10): e29117, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028986
3.
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
J Clin Oncol
; 41(17): 3149-3159, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098238
4.
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
Clin Cancer Res
; 29(8): 1546-1556, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749880
5.
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822669
6.
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
J Clin Oncol
; 39(29): 3229-3241, 2021 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319759
7.
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
J Clin Oncol
; 38(19): 2160-2169, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343642
8.
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study.
J Clin Oncol
; 38(24): 2741-2752, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530765